Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 24. Juni 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8035  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 160696  
   
First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study.
Front Immunol
Zhang W, Yang X, Chen H, Pu X, Tuohetashi R, Wu X, Xie Z, Wu D, Cai Y, Jin S, Guo X, Yao K, Chen Y, Jiang G.
PMID: 42338583 [PubMed - in process]


Tumor markers in rheumatoid arthritis -associated interstitial lung disease: a systematic review and meta-analysis.
BMC Rheumatol
Qiaoqian Z, Qing W, Bowen L, Qijiao W, Na W.
PMID: 42337778 [PubMed - as supplied by publisher]


Using machine learning algorithms based on laboratory indicators to establish a diagnostic model for lung cancer.
BMC Cancer
Wu J, Zhang L, Zhang Z, Gao S, Wang S, Zheng X, Xu X, Ding H, Shen H, Yan H.
PMID: 42337448 [PubMed - as supplied by publisher]


Biomass burning, PM2.5 peaks, and trends in lung adenocarcinoma diagnoses: an ecological study in São Paulo State, Brazil.
BJC Rep
Silva SB, Larssen HG, Colli LM.
PMID: 42337122 [PubMed - in process]


Implementing trust in non-small cell lung cancer diagnosis with a conformalized uncertainty-aware AI framework.
Nat Biomed Eng
Zhang X, Wang T, Yan C, Najdawi F, Zhou K, Ma Y, Cheung YM, Yeung MCF, Malin BA.
PMID: 42337062 [PubMed - as supplied by publisher]


Comment on "Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003".
Pract Radiat Oncol
Chen ST.
PMID: 42336600 [PubMed - in process]


TARGETED KNOCKDOWN: siRNA DELIVERY TO LUNG CANCER VIA MESOPOROUS SILICA NANOPARTICLES.
Crit Rev Oncol Hematol
Mukherjee M, Maiti AK, Dhara S, Chakraborty S, Datta A.
PMID: 42336067 [PubMed - as supplied by publisher]


Optimal Use of Targeted Therapy and Immunotherapy in Early-Stage, Resectable Non-Small Cell Lung Cancer.
Am Soc Clin Oncol Educ Book
Osarogiagbon RU, Cetnar JP, Aljumaily R.
PMID: 42335416 [PubMed - indexed for MEDLINE]


Diagnostic sensitivity and safety of visceral pleural biopsy under semi-rigid medical thoracoscopy in patients with undiagnosed exudative pleural effusions: a retrospective study.
Ther Adv Respir Dis
Xu R, Wen L, Tan F, Liu J, Li W, Liu D, Wang K.
PMID: 42335185 [PubMed - indexed for MEDLINE]


Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant cases.
PLoS One
Forero YJ, Kammer MN, McGann KC, Holmes H, Chen SC, Chen H, Argaw S, Khalil TA, Antic SL, Zou Y, Zuo L, Lasko TA, Landman BA, Deppen SA, Grogan EL, Maldonado F.
PMID: 42335041 [PubMed - indexed for MEDLINE]


Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC).
Cancer Immunol Immunother
Dudnik E, Nechushtan H, Rotem O, Hanovich E, Wollner M, Boikaner T, Fridman N, Ofer J, Ben-David MA, Reinhorn D.
PMID: 42334618 [PubMed - as supplied by publisher]


Multi-omics investigation of per- and polyfluoroalkyl substances in lung adenocarcinoma: comprehensive network toxicology, machine learning and molecular docking experiments.
Mol Divers
Li C, Zeng X, Mao Y, Liu Y, Nong S.
PMID: 42334505 [PubMed - as supplied by publisher]


Clinicopathological and Prognostic Disparities in Part-Solid Versus Pure Solid Pulmonary Nodules as Early-Stage Lung Adenocarcinoma.
Thorac Cancer
Li H, Yu R, Guo S, Wang Y, Gu Z, Fang W.
PMID: 42333986 [PubMed - indexed for MEDLINE]


Targeting Ceramide Metabolism to Overcome Osimertinib Resistance in EGFR-mutant Non-Small Cell Lung Cancer: An In Vitro, Network Pharmacology, and In Silico Study.
Anticancer Agents Med Chem
Selvi O, Sezer CV, Cengiz M, Aztopal N, Kutlu HM.
PMID: 42333846 [PubMed - as supplied by publisher]


Establishment of a prediction model for malignant probability of pulmonary nodules in an adenocarcinoma-predominant cohort.
PeerJ
Li F, Yu X, Xu K, Zhang G.
PMID: 42333223 [PubMed - indexed for MEDLINE]


PET/CT Radiomics-based assessment of tumor heterogeneity for predicting immunotherapy outcomes in advanced lung squamous cell carcinoma: a retrospective prognostic modeling study.
BMC Cancer
Zhang R, Li Y, Duan F, Wang X, Zhang M, Li P, Wang D.
PMID: 42332591 [PubMed - as supplied by publisher]


Association between the advanced lung cancer inflammation index and all-cause mortality in critically ill patients with atrial fibrillation.
Medicine (Baltimore)
Lin Y, Lin R, Yang D, Ye S, Zhang L, Lin Y.
PMID: 42332525 [PubMed - indexed for MEDLINE]


Effect of EGFR-TP53 co-mutation on the efficacy of EGFR-TKIs in patients with advanced NSCLC and therapeutic strategies: A retrospective study.
Medicine (Baltimore)
Feng X, Liu L.
PMID: 42332497 [PubMed - indexed for MEDLINE]


Modeling survival prognosis in female patients with bone metastases from lung adenocarcinoma: A retrospective study based on the SEER database and a Chinese cohort.
Medicine (Baltimore)
Li Z, Zhou Z, Chen X, Niu S.
PMID: 42332473 [PubMed - indexed for MEDLINE]


Study on the current status and influencing factors of psychological resilience in postoperative patients with non-small cell lung cancer.
Medicine (Baltimore)
Chen J.
PMID: 42332470 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 160696    Seite 1 von 8035  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1